May 9, 2019
TB Alliance and Partners Form Multidisciplinary Center for Translational TB Drug Research
New collaboration, supported by U.S. National Institutes of Health, to produce two new clinical stage TB drug candidates April 29, 2019
Joint Statement on Universal Health Coverage and TB Research
Moving Together to Build a Healthier World April 25, 2019
A Conversation with Karl Hofmann
Looking back and looking forward with the outgoing president of TB Alliance's Stakeholders Association April 18, 2019
TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens to Treat Tuberculosis
Regimens under clinical development include treatment options for drug-resistant forms of TB March 20, 2019
Statement on Building a Tuberculosis Free World: The Lancet Commission on Tuberculosis
This is an important moment to take stock of the milestones achieved in the fight against TB and to spur policymakers and funders to commit the necessary resources to end TB. February 5, 2019
Compound Studied in TB to be Evaluated in the Treatment of Leishmaniasis
Wellcome commits £10 million to DNDi to develop new generation of oral drugs to treat leishmaniasis January 23, 2019
Increased Commitment to Neglected Disease R&D, but TB Landscape Remains Largely Unchanged
Statement on 2018 G-FINDER Report January 18, 2019
Played Red Dead Redemption 2? Here’s what you should know about TB
Whether it’s 1899 or 2019, TB is a serious disease that poses a significant challenge to global health January 15, 2019